The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAARTon Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Tagungsbericht |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 377 |
---|---|
container_issue | 3 |
container_start_page | 369 |
container_title | |
container_volume | 53 |
creator | COOPER, Vanessa HORNE, Rob GELLAITRY, Grace VRIJENS, Bernard LANGE, Anne-Catherine FISHER, Martin WHITE, David |
description | |
format | Conference Proceeding |
fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_22530390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22530390</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_225303903</originalsourceid><addsrcrecordid>eNqNTstOg0AUnRhNrNV_uBuXJDwGBXe0xdRNSSrRZXOFSxmlM2Qu1OCf-LdOox_g6jxyzsk5E7MgldK7TxJ57ngcxp4MovhSXDG_-35wJ2U6E99lS_B06LEawDRQ6Iq8jdq3QzfBC1keGcpP5cwVKmetDCu9B9Q1LJCpU5pg4YAahuzNjAOss2xbGg1Z3ZIlNweDgbzBo3Lqyzu16t8QFEeyIBN4JfrgBzg92RTLMofnYayna3HRYMd084dzcfuYl8u11yNX2DUWdaV411t1QDvtwjCO_Cj1o__mfgCgE1kc</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype></control><display><type>conference_proceeding</type><title>The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAARTon Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study</title><source>Journals@Ovid LWW Legacy Archive</source><source>Open Access Journals</source><source>Journals@Ovid Complete</source><creator>COOPER, Vanessa ; HORNE, Rob ; GELLAITRY, Grace ; VRIJENS, Bernard ; LANGE, Anne-Catherine ; FISHER, Martin ; WHITE, David</creator><creatorcontrib>COOPER, Vanessa ; HORNE, Rob ; GELLAITRY, Grace ; VRIJENS, Bernard ; LANGE, Anne-Catherine ; FISHER, Martin ; WHITE, David</creatorcontrib><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; Human viral diseases ; Infectious diseases ; Medical sciences ; Microbiology ; Miscellaneous ; Viral diseases ; Virology</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2010, Vol.53 (3), p.369-377</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,776,780,785,786,4036,4037,23911,23912,25120</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22530390$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>COOPER, Vanessa</creatorcontrib><creatorcontrib>HORNE, Rob</creatorcontrib><creatorcontrib>GELLAITRY, Grace</creatorcontrib><creatorcontrib>VRIJENS, Bernard</creatorcontrib><creatorcontrib>LANGE, Anne-Catherine</creatorcontrib><creatorcontrib>FISHER, Martin</creatorcontrib><creatorcontrib>WHITE, David</creatorcontrib><title>The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAARTon Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study</title><title>Journal of acquired immune deficiency syndromes (1999)</title><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Human viral diseases</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Viral diseases</subject><subject>Virology</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2010</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNqNTstOg0AUnRhNrNV_uBuXJDwGBXe0xdRNSSrRZXOFSxmlM2Qu1OCf-LdOox_g6jxyzsk5E7MgldK7TxJ57ngcxp4MovhSXDG_-35wJ2U6E99lS_B06LEawDRQ6Iq8jdq3QzfBC1keGcpP5cwVKmetDCu9B9Q1LJCpU5pg4YAahuzNjAOss2xbGg1Z3ZIlNweDgbzBo3Lqyzu16t8QFEeyIBN4JfrgBzg92RTLMofnYayna3HRYMd084dzcfuYl8u11yNX2DUWdaV411t1QDvtwjCO_Cj1o__mfgCgE1kc</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>COOPER, Vanessa</creator><creator>HORNE, Rob</creator><creator>GELLAITRY, Grace</creator><creator>VRIJENS, Bernard</creator><creator>LANGE, Anne-Catherine</creator><creator>FISHER, Martin</creator><creator>WHITE, David</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope></search><sort><creationdate>2010</creationdate><title>The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAARTon Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study</title><author>COOPER, Vanessa ; HORNE, Rob ; GELLAITRY, Grace ; VRIJENS, Bernard ; LANGE, Anne-Catherine ; FISHER, Martin ; WHITE, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_225303903</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Human viral diseases</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Viral diseases</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>COOPER, Vanessa</creatorcontrib><creatorcontrib>HORNE, Rob</creatorcontrib><creatorcontrib>GELLAITRY, Grace</creatorcontrib><creatorcontrib>VRIJENS, Bernard</creatorcontrib><creatorcontrib>LANGE, Anne-Catherine</creatorcontrib><creatorcontrib>FISHER, Martin</creatorcontrib><creatorcontrib>WHITE, David</creatorcontrib><collection>Pascal-Francis</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>COOPER, Vanessa</au><au>HORNE, Rob</au><au>GELLAITRY, Grace</au><au>VRIJENS, Bernard</au><au>LANGE, Anne-Catherine</au><au>FISHER, Martin</au><au>WHITE, David</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAARTon Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study</atitle><btitle>Journal of acquired immune deficiency syndromes (1999)</btitle><date>2010</date><risdate>2010</risdate><volume>53</volume><issue>3</issue><spage>369</spage><epage>377</epage><pages>369-377</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-4135 |
ispartof | Journal of acquired immune deficiency syndromes (1999), 2010, Vol.53 (3), p.369-377 |
issn | 1525-4135 1944-7884 |
language | eng |
recordid | cdi_pascalfrancis_primary_22530390 |
source | Journals@Ovid LWW Legacy Archive; Open Access Journals; Journals@Ovid Complete |
subjects | Biological and medical sciences Fundamental and applied biological sciences. Psychology Human viral diseases Infectious diseases Medical sciences Microbiology Miscellaneous Viral diseases Virology |
title | The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAARTon Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T19%3A59%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=The%20Impact%20of%20Once-Nightly%20Versus%20Twice-Daily%20Dosing%20and%20Baseline%20Beliefs%20About%20HAARTon%20Adherence%20to%20Efavirenz-Based%20HAART%20Over%2048%20Weeks:%20The%20NOCTE%20Study&rft.btitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=COOPER,%20Vanessa&rft.date=2010&rft.volume=53&rft.issue=3&rft.spage=369&rft.epage=377&rft.pages=369-377&rft.issn=1525-4135&rft.eissn=1944-7884&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E22530390%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |